a drug being studied in the treatment of cancer. it blocks enzymes needed for cells to grow and divide and may kill cancer cells. panobinostat may also prevent the growth of new blood vessels that tumors need to grow. it is a type of histone deacetylase inhibitor and a type of antiangiogenesis agent. also called faridak and lbh589.
出典:Wikipedia
出典:『Wikipedia』 (2011/06/07 22:21 UTC 版)
Panobinostat (LBH-589) is an experimental drug developed by Novartis for the treatment of various cancers. It is a hydroxamic acid and acts as a non-selective HDAC inhibitor.